BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7690016)

  • 1. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.
    Crook J; Robertson S; Collin G; Zaleski V; Esche B
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):31-7. PubMed ID: 7690016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.
    Crook JM; Bahadur YA; Bociek RG; Perry GA; Robertson SJ; Esche BA
    Cancer; 1997 Jan; 79(2):328-36. PubMed ID: 9010106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative cell nuclear antigen in postradiotherapy prostate biopsies.
    Crook J; Robertson S; Esche B
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):303-8. PubMed ID: 7928458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.
    Crook J; Malone S; Perry G; Bahadur Y; Robertson S; Abdolell M
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):355-67. PubMed ID: 10974448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
    Liebross RH; Pollack A; Lankford SP; von Eschenbach AC; Zagars GK
    Urology; 1998 Oct; 52(4):647-52. PubMed ID: 9763087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients.
    Crook JM; Perry GA; Robertson S; Esche BA
    Urology; 1995 Apr; 45(4):624-31; discussion 631-2. PubMed ID: 7716843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure.
    Crook JM; Choan E; Perry GA; Robertson S; Esche BA
    Urology; 1998 Apr; 51(4):566-72. PubMed ID: 9586608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.
    Laverdière J; Gomez JL; Cusan L; Suburu ER; Diamond P; Lemay M; Candas B; Fortin A; Labrie F
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):247-52. PubMed ID: 9069293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy.
    Borghede G; Aldenborg F; Wurzinger E; Johansson KA; Hedelin H
    Br J Urol; 1997 Aug; 80(2):247-55. PubMed ID: 9284197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percent free prostate-specific antigen after radiotherapy for prostate cancer.
    Crook JM; Bunting PS
    Urology; 1998 Jul; 52(1):100-5. PubMed ID: 9671878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy.
    Forman JD; Oppenheim T; Liu H; Montie J; McLaughlin PW; Porter AT
    Prostate; 1993; 23(3):235-43. PubMed ID: 7694267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
    Feneley MR; Webb JA; McLean A; Kirby RS
    Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate brachytherapy: treatment strategies.
    Stone NN; Stock RG
    J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW; Schild SE; Vora SA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer.
    Selek U; Lee A; Levy L; Kuban DA
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):963-7. PubMed ID: 14575826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.
    Stokes SH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.